Presently, Nawal Ouzren holds the position of Chief Executive Officer & Director at Sensorion SAS. Ms. Ouzren is also on the board of Arena Pharmaceuticals, Inc.

In her past career Ms. Ouzren occupied the position of Group Vice President-Rare Genetic Diseases at Shire Plc, Vice President at Baxter SAS and Vice President-Global Hemophilia Franchise at Baxalta France SAS.

She received a graduate degree from Technical University of Berlin and a graduate degree from Université de Technologie de Compiègne.